David Tapolczay - 01 Dec 2023 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Director
Signature
/s/ David Tapolczay
Issuer symbol
CDT
Transactions as of
01 Dec 2023
Net transactions value
+$1,642,966
Form type
4
Filing time
05 Dec 2023, 17:20:19 UTC
Previous filing
26 Sep 2023
Next filing
24 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Stock Option (Right to Buy) Award $1,642,966 +298,179 $5.51 298,179 01 Dec 2023 Common Stock 298,179 $5.51 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.
F2 The stock options were granted with a ten-year term and vest 25% on each of the first four anniversaries of the vesting commencement date, which is September 22, 2023.